Project Number 2021PV Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2021 View Full Project Details for Targeting tauopathies with antisense oligonucleotides to Synaptogyrin-3 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator Verstreken, Patrik Principal Investigator Verstreken, Patrik Awardee Organization VIB Awardee State N/A Contact PI Country Belgium Project Detail Funding Opportunity Announcement 2021 Research Grants FY Overall Cost $129,375 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States Program Official CureAlzFund
